Company
Corcept Therapeutics
We are unlocking the potential of cortisol modulation to revolutionize the treatment of serious diseases.
Also known as Corcept Therapeutics Incorporated
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Employees
- 750+ employeesSource (opens in a new tab)
- Legal name
- Corcept Therapeutics Incorporated
- corcept.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We’re leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR).
Funding snapshot
- Total raised
- $26.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $525K2012-03-25
Funding rounds
- Round, 2012
- $525K2012-03-25, SEC form D sold, 44 investors
- Round, 2010
- $7.7M2010-04-21, SEC form D sold, 41 investors
- Round, 2009
- $18M2009-10-16, SEC form D sold, 43 investors
Products
- Other
- Korlym
Loading relationship preview